SIEGALL CLAY B (CIK 1167496) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-27). Recent activity: Buy IMNM (180,000 shares), Buy STTK (62,500 shares), Buy STTK (128,054 shares), Buy IMNM (25,450 shares), Buy IMNM (4,729 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Immunome Inc. (IMNM) | President and CEO | Buy | 180,000 | $0 |
| 2026-06-11 | Shattuck Labs, Inc. (STTK) | Director | Buy | 62,500 | $250,000 |
| 2026-05-27 | Shattuck Labs, Inc. (STTK) | Director | Buy | 128,054 | $138,887 |
| 2026-03-31 | Immunome Inc. (IMNM) | President and CEO | Buy | 25,450 | $500,602 |
| 2025-12-30 | Immunome Inc. (IMNM) | President and CEO | Buy | 4,729 | $100,018 |
| 2025-12-22 | Immunome Inc. (IMNM) | President and CEO | Buy | 7,278 | $149,053 |
| 2025-12-22 | Immunome Inc. (IMNM) | President and CEO | Sell | 200,000 | $0 |
| 2025-12-18 | Immunome Inc. (IMNM) | President and CEO | Buy | 46,511 | $999,986 |
| 2025-08-27 | Shattuck Labs, Inc. (STTK) | Director | Buy | 128,054 | $111,407 |
| 2025-03-26 | Immunome Inc. (IMNM) | President and CEO | Buy | 137,100 | $999,459 |
Source: SEC Form 4 filings · as of 2026-07-27